Salvage surgery for intratumoral regrowth after a marked response to atezolizumab plus bevacizumab in borderline resectable hepatocellular carcinoma
Clinical Journal of Gastroenterology · 18.11.2026
DOI: 10.1007/s12328-026-02492-0 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Journal of Gastroenterology, online erschienen am 18.11.2026. Verfasst von Atsuhiko Ochi und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Asahi General Hospital, I-1326, Asahi, Chiba, 289-2511, Japan. Die Arbeit nennt 21 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Surgery, Asahi General Hospital, I-1326, Asahi, Chiba, 289-2511, Japan.
- Department of Surgery, Asahi General Hospital, I-1326, Asahi, Chiba, 289-2511, Japan. keigo0924@gmail.com.
- Department of Gastroenterology, Asahi General Hospital, I-1326, Asahi, Chiba, 289-2511, Japan.
Zitieren
APA
Ochi, A., Tani, K., Itobayashi, E., Sasaki, N., Mori, K., & Nagai, M. (2026). Salvage surgery for intratumoral regrowth after a marked response to atezolizumab plus bevacizumab in borderline resectable hepatocellular carcinoma. Clinical Journal of Gastroenterology. https://doi.org/10.1007/s12328-026-02492-0
Vancouver
Ochi A, Tani K, Itobayashi E, Sasaki N, Mori K, Nagai M. Salvage surgery for intratumoral regrowth after a marked response to atezolizumab plus bevacizumab in borderline resectable hepatocellular carcinoma. Clinical Journal of Gastroenterology. 2026. doi:10.1007/s12328-026-02492-0
BibTeX
@article{Ochi2026,
author = {Ochi, Atsuhiko and Tani, Keigo and Itobayashi, Ei and Sasaki, Naomichi and Mori, Kazuhiro and Nagai, Motoki},
title = {Salvage surgery for intratumoral regrowth after a marked response to atezolizumab plus bevacizumab in borderline resectable hepatocellular carcinoma},
journal = {Clinical Journal of Gastroenterology},
year = {2026},
doi = {10.1007/s12328-026-02492-0}
}
EUVIMED